Search filters

List of works by Piotr Rutkowski

A durable complete response to immunotherapy in a patient with metastatic alveolar soft part sarcoma

scientific article published on 22 June 2020

A phase II study of a human anti-PDGFRα monoclonal antibody (olaratumab, IMC-3G3) in previously treated patients with metastatic gastrointestinal stromal tumors.

scientific article published in March 2017

A prospective observational safety study of patients with BRAFV 600 -mutated unresectable or metastatic melanoma treated with vemurafenib (Zelboraf Safety Study)

scientific article published on 10 February 2019

ASO Author Reflections: The Importance of Defining Tumor Rupture in GIST Before Research

scientific article published on 08 August 2019

Abstract LB-295: Detection of oncogenic kinase mutations in circulating plasma DNA and correlation with clinical benefit in the phase III GRID study of regorafenibvsplacebo in TKI-refractory metastatic GIST

article

Access to innovative medicines for metastatic melanoma worldwide: Melanoma World Society and European Association of Dermato-oncology survey in 34 countries

scientific article published on 31 October 2018

Activation of blood coagulation and the activity of cancer procoagulant (EC 3.4.22.26) in breast cancer patients

scientific article published on 01 November 1999

Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 'CREATE'.

scientific article published on 18 September 2017

Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 ‘CREATE’

scientific article published on 01 February 2019

Activity and safety of crizotinib in patients with alveolar soft part sarcoma with rearrangement of TFE3. European Organization for Research and Treatment of Cancer (EORTC) phase 2 trial 90101 "CREATE".

scientific article published on 5 December 2017

Activity of Pazopanib and Trabectedin in Advanced Alveolar Soft Part Sarcoma

scientific article

Addition of aldosterone receptor blocker to dual renin-angiotensin-aldosterone blockade leads to limitation of tubulointerstitial injury of kidney

scientific article published in November 2007

Adherence to imatinib therapy in patients with gastrointestinal stromal tumors

scientific article published on 07 August 2013

Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma

scientific article published on 10 September 2017

Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma

scientific article published on 15 April 2018

Adjuvant ganglioside GM2-KLH/QS-21 vaccination versus observation after resection of primary tumor > 1.5 mm in patients with stage II melanoma: results of the EORTC 18961 randomized phase III trial

scientific article

Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial ⬇️

journal article from 'The Lancet Oncology' published in 2021

Adjuvant therapy with pegylated interferon-alfa2b vs observation in stage II B/C patients with ulcerated primary: Results of the European Organisation for Research and Treatment of Cancer 18081 randomised trial

scientific article published on 26 May 2020

Adjuvant vaccination with melanoma antigen-pulsed dendritic cells in stage III melanoma patients

scientific article published on 01 December 2012

Adjuvant vemurafenib in resected, BRAFV600 mutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial

scientific article published on 21 February 2018

Advanced Antimicrobial Materials and Applications: Maleic Anhydride Antimicrobial Polymers

scientific article published on 5 November 2020

Advances in molecular characterization and targeted therapy in dermatofibrosarcoma protuberans

scientific article published on 30 March 2011

Alterations of routine blood tests in adult patients with soft tissue sarcomas: Relationships to cytokine serum levels and prognostic significance

scientific article published on 01 October 2001

An open-label, multicentre safety study of vemurafenib in patients with BRAFV600-mutant metastatic melanoma: final analysis and a validated prognostic scoring system

scientific article published on 20 December 2018

An open-label, phase 2 study evaluating the efficacy and safety of the anti-IGF-1R antibody cixutumumab in patients with previously treated advanced or metastatic soft-tissue sarcoma or Ewing family of tumours

scientific article published on 5 July 2013

An update on the safety of nivolumab for the treatment of advanced melanoma

scientific article published on 15 April 2020

Anthracycline, Gemcitabine, and Pazopanib in Epithelioid Sarcoma: A Multi-institutional Case Series

scientific article published on 13 September 2018

Anti-programmed cell death-1 therapy in octogenarian and nonagenarian advanced/metastatic melanoma patients

scientific article published on 06 November 2020

Application of clay minerals and their derivatives in adsorption from gaseous phase

scientific article published in December 2021

Association Between Immune-Related Adverse Events and Recurrence-Free Survival Among Patients With Stage III Melanoma Randomized to Receive Pembrolizumab or Placebo: A Secondary Analysis of a Randomized Clinical Trial

scientific article published on 02 January 2020

Atezolizumab, vemurafenib, and cobimetinib as first-line treatment for unresectable advanced BRAFV600 mutation-positive melanoma (IMspire150): primary analysis of the randomised, double-blind, placebo-controlled, phase 3 trial

scientific article published on 01 June 2020

Avapritinib in advanced PDGFRA D842V-mutant gastrointestinal stromal tumour (NAVIGATOR): a multicentre, open-label, phase 1 trial

scientific article published on 01 July 2020

BRAF and MEK inhibitors rechallenge as effective treatment for patients with metastatic melanoma

scientific article published on 25 March 2020

BRAF inhibition curtails IFN-gamma-inducible PD-L1 expression and upregulates the immunoregulatory protein galectin-1 in melanoma cells

scientific article published on 24 April 2020

Badania kontrolne po leczeniu w najczęstszych nowotworach litych u dorosłych

scientific article published on 6 November 2014

Best practices for the management of local-regional recurrent chordoma: a position paper by the Chordoma Global Consensus Group.

scientific article

Binimetinib versus dacarbazine in patients with advanced NRAS-mutant melanoma (NEMO): a multicentre, open-label, randomised, phase 3 trial.

scientific article published on 8 March 2017

Biochars obtained from freshwater biomass—green macroalga and hornwort as Cr(III) ions sorbents

scientific article published on 24 February 2020

Biomarkers of alcohol abuse. Part II. New biomarkers and their interpretation

scientific article published in January 2010

Blood neutrophil-to-lymphocyte ratio is associated with prognosis in advanced gastrointestinal stromal tumors treated with imatinib

scientific article published on 18 April 2018

Body mass index (BMI) and outcome of metastatic melanoma patients receiving targeted therapy and immunotherapy: a multicenter international retrospective study

scientific article published on 01 November 2020

Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

scientific article published on 01 October 2018

Brostallicin versus doxorubicin as first-line chemotherapy in patients with advanced or metastatic soft tissue sarcoma: an European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group randomised phase II and pharmaco

scientific article published on 8 November 2013

Candidate diagnostic miRNAs that can detect cancer in prostate biopsy.

scientific article

Cell-free DNA BRAF V600E measurements during BRAF inhibitor therapy of metastatic melanoma: long-term analysis

scientific article published on 06 February 2020

Clinical outcomes of patients with advanced gastrointestinal stromal tumors: safety and efficacy in a worldwide treatment-use trial of sunitinib

scientific article

Clinical utility of the new American Joint Committee on Cancer staging system for gastrointestinal stromal tumors: current overall survival after primary tumor resection

scientific article

Clinical, pathological and surgical characteristics of duodenal gastrointestinal stromal tumor and their influence on survival: a multi-center study.

scientific article published on 28 July 2012

Clinicopathological Features and Prognostic Factors of Primary Acral Melanomas in Caucasians

scientific article published on 16 September 2020

Cobimetinib plus atezolizumab in BRAF<sup>V600</sup> wild-type melanoma: primary results from the randomized phase 3 IMspire170 study

scientific article published on 10 December 2020

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

scientific article (publication date: 2 July 2015)

Combined Therapy of Gastrointestinal Stromal Tumors.

scientific article

Comparison between two widely used laboratory methods in BRAF V600 mutation detection in a large cohort of clinical samples of cutaneous melanoma metastases to the lymph nodes.

scientific article

Comparison of dabrafenib and trametinib combination therapy with vemurafenib monotherapy on health-related quality of life in patients with unresectable or metastatic cutaneous BRAF Val600-mutation-positive melanoma (COMBI-v): results of a phase 3, o

article

Comparison of seventh and eighth edition of AJCC staging system in melanomas at locoregional stage.

scientific article

Coordinated expression and genetic polymorphisms in Grainyhead-like genes in human non-melanoma skin cancers

scientific article published on 4 January 2018

Coronavirus Disease (COVID-19) Outbreak: Hypofractionated Radiotherapy in Soft Tissue Sarcomas as a Valuable Option in the Environment of Limited Medical Resources and Demands for Increased Protection of Patients

scientific article published on 05 June 2020

Correction to: Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC)

Correction: Use of extracellular vesicles from lymphatic drainage as surrogate markers of melanoma progression and mutation

scholarly article by Susana García-Silva et al published 6 May 2019 in Journal of Experimental Medicine

Corrections to "Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up"

scientific article published on 01 October 2018

Corrections to "Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up"

scientific article published on 01 October 2018

Correlation of Immunological and Molecular Profiles with Response to Crizotinib in Alveolar Soft Part Sarcoma: An Exploratory Study Related to the EORTC 90101 "CREATE" Trial

scientific article published on 19 May 2022

Correlation of KIT and PDGFRA mutational status with clinical benefit in patients with gastrointestinal stromal tumor treated with sunitinib in a worldwide treatment-use trial

scientific article published on 15 January 2016

Crizotinib achieves long-lasting disease control in advanced papillary renal-cell carcinoma type 1 patients with MET mutations or amplification. EORTC 90101 CREATE trial

scientific article published on 14 November 2017

Crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumours with and without anaplastic lymphoma kinase gene alterations (European Organisation for Research and Treatment of Cancer 90101 CREATE): a multicentre, single-drug,

scientific article published on 12 April 2018

Current Diagnosis and Treatment Options for Cutaneous Adnexal Neoplasms with Apocrine and Eccrine Differentiation ⬇️

journal article from 'International Journal of Molecular Sciences' published in 2021

Current status and unanswered questions on the use of Denosumab in giant cell tumor of bone

scientific article

Current treatment options for dermatofibrosarcoma protuberans

scientific article

Cutaneous melanoma with nodal metastases in elderly people

scientific article published in August 2010

Cutaneous melanoma – guidelines for diagnostics and therapy in 2016

scientific article published in 2016

Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: Correlations with local tumor extent and prognosis

scientific article published on 01 November 2003

Cytokine serum levels in soft tissue sarcoma patients: correlations with clinico-pathological features and prognosis

scientific article published in August 2002

Czerniaki skóry — zasady postępowania diagnostyczno-terapeutycznego w 2016 roku

scientific article published on 9 February 2016

Dabrafenib for the treatment of BRAF V600-positive melanoma: a safety evaluation

scientific article published on 11 July 2014

Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial

scientific article (publication date: 28 July 2012)

Defining Rupture in Gastrointestinal Stromal Tumor: Semantics and Prognostic Value.

scientific article

Defining Tumor Rupture in Gastrointestinal Stromal Tumor

Defining the role of neoadjuvant systemic therapy in high-risk retroperitoneal sarcoma: A multi - institutional study from the Transatlantic Australasian Retroperitoneal Sarcoma Working Group

scientific article published on 18 November 2020

Denosumab Treatment for Giant Cell Tumor of the Spine Including the Sacrum

scientific article published on 08 October 2020

Denosumab in patients with giant-cell tumour of bone: a multicentre, open-label, phase 2 study.

scientific article

Denosumab treatment of inoperable or locally advanced giant cell tumor of bone

scientific article published on 12 October 2016

Denosumab treatment of inoperable or locally advanced giant cell tumor of bone - Multicenter analysis outside clinical trial

scientific article published on 31 March 2018

Dermatofibrosarcoma protuberans and gastrointestinal stromal tumor as models for targeted therapy in soft tissue sarcomas

scientific article

Detection of SS18-SSX1/2 fusion transcripts in circulating tumor cells of patients with synovial sarcoma

Detection of circulating melanoma cells in peripheral blood by a two-marker RT-PCR assay

scientific article published on 01 February 2001

Detection of melanoma cells in the lymphatic drainage after lymph node dissection in melanoma patients by using two-marker reverse transcriptase-polymerase chain reaction assay.

scientific article published on 15 October 2004

Development and validation of a nomogram to predict recurrence and melanoma-specific mortality in patients with negative sentinel lymph nodes

article

Development and validation of prognostic nomograms for metastatic gastrointestinal stromal tumour treated with imatinib

scientific article published on 19 March 2015

Development of immunity-related adverse events correlates with baseline clinical factors, survival and response to anti-PD-1 treatment in patients with inoperable or metastatic melanoma

scientific article published on 31 May 2021

Developments in targeted therapy of advanced gastrointestinal stromal tumors.

scientific article published on June 2008

Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network

scientific article published on 03 September 2020

Diagnostic yield and safety of endoscopic ultrasound-guided trucut [corrected] biopsy in patients with gastric submucosal tumors: a prospective study.

scientific article published in April 2009

Differences in recurrence and survival of extremity liposarcoma subtypes

scientific article published on 06 April 2018

Different factors are responsible for predicting relapses after primary tumors resection and for imatinib treatment outcomes in gastrointestinal stromal tumors

scientific article published in November 2007

Downstream and intermediate interactions of synovial sarcoma-associated fusion oncoproteins and their implication for targeted therapy

scientific article published on 25 March 2012

Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first-line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tiss

scientific article published on 04 March 2020

Doxorubicin-based adjuvant chemotherapy in soft tissue sarcoma: pooled analysis of two STBSG-EORTC phase III clinical trials.

scientific article published on 6 October 2014

ECCO essential requirements for quality cancer care: Melanoma.

scientific article published on 2 January 2018

ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016

scientific article (publication date: 2016)

ESMO consensus conference recommendations on the management of locoregional melanoma: the ESMO Guidelines Committee

scientific article published on 22 July 2020

ESMO consensus conference recommendations on the management of metastatic melanoma: the ESMO Guidelines Committee

scientific article published on 22 July 2020

Effect of isopropyl methylphosphonofluoridate (IMPF) poisoning on selected immunological parameters of angiogenesis

scientific article published on 01 January 2014

Effect of nivolumab on health-related quality of life in patients with treatment-naïve advanced melanoma: results from the phase III CheckMate 066 study

scientific article published on 12 July 2016

Effective treatment of recurrent, advanced dermatofibrosarcoma protuberans by electrochemotherapy

scientific article published on 01 April 2013

Effects of time interval between primary melanoma excision and sentinel node biopsy on positivity rate and survival.

scientific article published on 23 September 2016

Efficacy and Safety Outcomes in Patients With Advanced Melanoma Who Discontinued Treatment With Nivolumab and Ipilimumab Because of Adverse Events: A Pooled Analysis of Randomized Phase II and III Trials

scientific article published on 25 August 2017

Efficacy and economic value of adjuvant imatinib for gastrointestinal stromal tumors

scientific article

Efficacy and safety of ipilimumab therapy in patients with metastatic melanoma: a retrospective multicenter analysis

scientific article published on 28 June 2013

Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial

scientific article

Efficacy of ipilimumab after anti-PD-1 therapy in sequential treatment of metastatic melanoma patients - Real world evidence

scientific article published on 15 June 2020

Efficacy of neoadjuvant hypofractionated radiotherapy in patients with locally advanced myxoid liposarcoma

scientific article

Electrochemotherapy in the treatment of metastatic malignant melanoma: a prospective cohort study by InspECT.

scientific article published on 24 January 2017

Emergency surgery in the era of molecular treatment of solid tumours

scientific article published on February 2009

Epidermal growth factor receptor (EGFR) status in chordoma.

scientific article

Epithelioid Sarcoma-From Genetics to Clinical Practice

scientific article published on 29 July 2020

Etoposide and carbo-or cisplatin combination therapy in refractory or relapsed Ewing sarcoma: A large retrospective study

scholarly article by Annemiek M. van Maldegem et al published 22 September 2014 in Pediatric Blood Cancer

Evaluation of Two Dosing Regimens for Nivolumab in Combination With Ipilimumab in Patients With Advanced Melanoma: Results From the Phase IIIb/IV CheckMate 511 Trial

scientific article published on 27 February 2019

Evaluation of the use and efficacy of (neo)adjuvant chemotherapy in angiosarcoma: a multicentre study

scientific article published on 01 August 2020

Expression of CD34 in gastric cancer and its correlation with histology, stage, proliferation activity, p53 expression and apoptotic index

scientific article published in January 2001

Extended adjuvant therapy with imatinib in patients with gastrointestinal stromal tumors : recommendations for patient selection, risk assessment, and molecular response monitoring

scientific article published on February 2013

External validation of a multi-institutional retroperitoneal sarcoma nomogram

scientific article

First-line treatment of advanced/metastatic melanoma with anti-PD-1 antibodies: multicenter experience in Poland

scientific article published on 23 December 2020

Five-Year Outcomes With Nivolumab in Patients With Wild-Type BRAF Advanced Melanoma

scientific article published on 30 September 2020

Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma.

scientific article

Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma

scientific article published on 28 September 2019

Five-year outcomes from a phase 3 METRIC study in patients with BRAF V600 E/K-mutant advanced or metastatic melanoma.

scientific article

Follow-up in melanoma patients

scientific article

Follow-up in soft tissue sarcomas

scientific article

Frequent mono-allelic loss associated with deficient PTEN expression in imatinib-resistant gastrointestinal stromal tumors

scientific article published on 18 April 2014

From Molecular Biology to Novel Immunotherapies and Nanomedicine in Uveal Melanoma

scientific article published in February 2024

Functional and symptom impact of trametinib versus chemotherapy in BRAF V600E advanced or metastatic melanoma: quality-of-life analyses of the METRIC study

scientific article published on 6 February 2014

Functional features of gene expression profiles differentiating gastrointestinal stromal tumours according to KIT mutations and expression

scientific article

Functional outcome of surgical treatment of adults with extremity osteosarcoma after megaprosthetic reconstruction-single-center experience.

scientific article

Gastrointestinal Pathologies in Patients After Successful Renal Transplantation-A Pilot Study

scientific article published on June 2016

Gastrointestinal Stromal Tumors

scientific article published on 16 October 2018

Gastrointestinal Stromal Tumors

Gastrointestinal stromal tumors: key to diagnosis and choice of therapy

scientific article published on January 2008

Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

scientific article published on 01 October 2018

Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

scientific article published in October 2018

Gene expression profiling of peripheral blood cells: new insights into Ewing sarcoma biology and clinical applications

scientific article

Genetic polymorphisms may influence the vertical growth rate of melanoma

article published in 2018

Genetics of rare mesenchymal tumors: implications for targeted treatment in DFSP, ASPS, CCS, GCTB and PEComa

scientific article published on 02 April 2014

Genomic index predicts clinical outcome of intermediate-risk gastrointestinal stromal tumours, providing a new inclusion criterion for imatinib adjuvant therapy

scientific article published on 6 November 2014

Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†.

scientific article

Has the Outcome for Patients Who Undergo Resection of Primary Retroperitoneal Sarcoma Changed Over Time? A Study of Time Trends During the Past 15 years

scientific article published on 18 October 2020

Health-related quality of life in patients with fully resected BRAFV600 mutation-positive melanoma receiving adjuvant vemurafenib.

scientific article

Health-related quality of life results from the phase III CheckMate 067 study.

scientific article published on 22 June 2017

Her2, EGFR and TOPIIA gene amplification and protein expression in synovial sarcoma before and after combined treatment

scientific article published in January 2009

High baseline neutrophil-to-lymphocyte ratio predicts worse outcome in patients with metastatic BRAF-positive melanoma treated with BRAF and MEK inhibitors

scientific article published on 01 October 2018

High frequency ultrasonography of the skin and its role as an auxillary tool in diagnosis of benign and malignant cutaneous tumors--a comparison of two clinical cases

scientific article published in January 2015

Hypofractionated Radiotherapy in Locally Advanced Myxoid Liposarcomas of Extremities or Trunk Wall: Results of a Single-Arm Prospective Clinical Trial

scientific article published on 01 August 2020

IDH1/2 Mutations Predict Shorter Survival in Chondrosarcoma.

scientific article published on 28 February 2018

Imatinib mesylate in advanced dermatofibrosarcoma protuberans: pooled analysis of two phase II clinical trials

scientific article

Immune checkpoint inhibitors therapy in older patients (≥ 70 years) with metastatic melanoma: a multicentre study.

scientific article

Immunotherapy Bridge 2017 and Melanoma Bridge 2017: meeting abstracts

scientific article published on 15 January 2018

Immunotherapy of melanoma

scientific article published on 05 March 2018

Immunotherapy of solid tumors: how safely treat the patients

scientific article published on 24 April 2020

Impact of COVID-19 on anxiety levels among patients with cancer actively treated with systemic therapy

scientific article published on 01 October 2020

Impact of chemotherapy in uterine sarcoma (UtS): review of 13 clinical trials from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) involving advanced/metastatic UtS compared to other soft tissue sarcoma (STS) patients treated with first line ch

scientific article published on 18 May 2016

Improved overall survival in melanoma with combined dabrafenib and trametinib

scientific article

Improved survival with MEK inhibition in BRAF-mutated melanoma

scientific article (publication date: 12 July 2012)

Improvement of Blood Pressure Control in Renal Transplant Recipients-Retrospective Longitudinal Study.

scientific article

In transit/local recurrences in melanoma patients after sentinel node biopsy and therapeutic lymph node dissection

scientific article published on 01 December 2005

Increased cancer risk of heterozygotes with NBS1 germline mutations in Poland

scientific article published in August 2004

Increased rate of cholesterologenesis--a possible cause of hypercholesterolemia in experimental chronic renal failure in rats

scientific article

Introduction to the special issue of European Journal of Surgical Oncology: New roads in melanoma management

scientific article published on 14 December 2016

Ipilimumab 10 mg/kg versus ipilimumab 3 mg/kg in patients with unresectable or metastatic melanoma: a randomised, double-blind, multicentre, phase 3 trial

scientific article published on 27 March 2017

Is the Surgical Margin in Gastrointestinal Stromal Tumors Different?

scientific article published on 24 August 2018

KEYNOTE-716: Phase III study of adjuvant pembrolizumab versus placebo in resected high-risk stage II melanoma

scientific article published on 24 December 2019

KIT and PDGFRA mutations and the risk of GI stromal tumor recurrence

scientific article published on 20 January 2015

Long term follow up of the EORTC 18952 trial of adjuvant therapy in resected stage IIB-III cutaneous melanoma patients comparing intermediate doses of interferon-alpha-2b (IFN) with observation: Ulceration of primary is key determinant for IFN-sensi

scientific article published on 17 January 2016

Long-term follow-up in adults with extremity osteosarcoma: comparison of different surgical procedures - single-center experience

scientific article published on 25 November 2019

Long-term follow-up of patients with GIST undergoing metastasectomy in the era of imatinib -- analysis of prognostic factors (EORTC-STBSG collaborative study).

scientific article published on 15 January 2014

Long-term outcome of dasatinib first-line treatment in gastrointestinal stromal tumor: A multicenter, 2-stage phase 2 trial (Swiss Group for Clinical Cancer Research 56/07).

scientific article published on 9 January 2018

Long-term outcomes in patients with BRAF V600-mutant metastatic melanoma receiving dabrafenib monotherapy: Analysis from phase 2 and 3 clinical trials

scientific article published on 01 January 2020

Long-term results of therapy with sunitinib in metastatic alveolar soft part sarcoma

scientific article

Long-term results of treatment of advanced dermatofibrosarcoma protuberans (DFSP) with imatinib mesylate - The impact of fibrosarcomatous transformation.

scientific article

Longer Follow-Up Confirms Recurrence-Free Survival Benefit of Adjuvant Pembrolizumab in High-Risk Stage III Melanoma: Updated Results From the EORTC 1325-MG/KEYNOTE-054 Trial

scientific article published on 18 September 2020

Low-overpotential full water splitting with metal-free self-supported electrodes obtained by amination of oxidised carbon cloth

scientific article published in 2022

Lymph node status and survival in cutaneous malignant melanoma--sentinel lymph node biopsy impact

scientific article

MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial

scientific article published on 13 June 2018

Malignant peripheral nerve sheath tumors - Outcomes and prognostic factors based on the reference center experience

scientific article published on 12 September 2020

Management Strategies for Adults with Locally Advanced, Unresectable or Metastatic Malignant Perivascular Epithelioid Cell Tumor (PEComa): Challenges and Solutions

scientific article published in 2023

Management of Renin-Angiotensin-Aldosterone System Blockade in Kidney Transplant Recipients

scientific article published on 15 March 2018

Management of the "Other" retroperitoneal sarcomas

scientific article published on 11 November 2017

Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015

scientific article

Melanoma early detection and awareness: how countries developing melanoma awareness programs could benefit from melanoma-proficient countries

scientific article published on January 2015

Melanoma without a detectable primary site with metastases to lymph nodes

scientific article published on 7 May 2010

Melanoma-derived small extracellular vesicles induce lymphangiogenesis and metastasis through an NGFR-dependent mechanism

scientific article published on 25 November 2021

Metastatic potential is determined early in synovial sarcoma development and reflected by tumor molecular features

scientific article published on 16 May 2014

MiR-17-92 and miR-221/222 cluster members target KIT and ETV1 in human gastrointestinal stromal tumours

scientific article published on 22 August 2013

Molecular Biology of Osteosarcoma

scientific article published on 31 July 2020

Molecular Comparison of Imatinib-Naïve and Resistant Gastrointestinal Stromal Tumors: Differentially Expressed microRNAs and mRNAs

scientific article published on 24 June 2019

Molecular alterations in clinical stage III cutaneous melanoma: Correlation with clinicopathological features and patient outcome.

scientific article

Molecular and biochemical testing in stage III melanoma: multimarker reverse transcriptase-polymerase chain reaction assay of lymph fluid after lymph node dissection and preoperative serum lactate dehydrogenase level.

scientific article published on 4 July 2008

Molecular characterization and patient outcome of melanoma nodal metastases and an unknown primary site.

scientific article

Molecular staging by multimarker reverse transcriptase-polymerase chain reaction assay of lymphatic drainage and blood from melanoma patients after lymph node dissection

scientific article published on 01 August 2008

More than 5000 patients with metastatic melanoma in Europe per year do not have access to new life-saving drugs

More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatments

scientific article published on 2 March 2017

Multifactoral analysis of determinators for renal injury in essential hypertension

scientific article published on 01 January 2006

Multimarker reverse transcriptase-polymerase chain reaction assay in lymphatic drainage and sentinel node tumor burden

scientific article

Multimodal Treatment of Advanced Mucosal Melanoma in the Era of Modern Immunotherapy

scientific article published on 26 October 2020

Multiple RT-PCR tyrosinase testing reveals that melanoma cells circulate in the blood of melanoma patients at the frequency more than 10 times below the detection threshold

scientific article published on 01 August 2002

Mutation profile of primary subungual melanomas in Caucasians

scientific article published on 23 June 2020

NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act.In.Sarc): a multicentre, phase 2-3, randomised, controlled trial

scientific article published on 08 July 2019

Natural history of well-differentiated liposarcoma of the extremity compared to patients treated with surgery

scientific article published on 09 April 2019

Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC)

Neoadjuvant Treatment Options in Soft Tissue Sarcomas

scientific article published on 26 July 2020

Neoadjuvant imatinib in locally advanced gastrointestinal stromal tumors (GIST): the EORTC STBSG experience

scientific article published on 13 June 2013

New or interesting records of lichenicolous fungi from Poland I ⬇️

scientific article published on 7 November 2002

News from the melanoma sessions of the European Cancer Congress 2017.

scientific article published on 17 March 2017

Nilotinib versus imatinib as first-line therapy for patients with unresectable or metastatic gastrointestinal stromal tumours (ENESTg1): a randomised phase 3 trial

scientific article published on 14 April 2015

Nivolumab improved survival vs dacarbazine in patients with untreated advanced melanoma

article

Nivolumab in previously untreated melanoma without BRAF mutation

scientific article (publication date: 22 January 2015)

Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial

scientific article published on 22 October 2018

Nutrition and Vascular Supply of Retinal Ganglion Cells during Human Development

scientific article

Oncogenic osteomalacia associated with phosphaturic mesenchymal tumour, mixed connective tissue type of the knee.

scientific article published on January 2009

Other malignant neoplasms in patients with gastrointestinal stromal tumors (GIST).

scientific article

Other targetable sarcomas

scientific article

Outcome of First-Line Systemic Treatment for Unresectable Conventional, Dedifferentiated, Mesenchymal, and Clear Cell Chondrosarcoma

scientific article published on 06 August 2018

Outcome of patients with platelet-derived growth factor receptor alpha-mutated gastrointestinal stromal tumors in the tyrosine kinase inhibitor era.

scientific article

Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.

scientific article published on 11 September 2017

Overall survival at 5 years of follow-up in a phase III trial comparing ipilimumab 10 mg/kg with 3 mg/kg in patients with advanced melanoma

scientific article published on 01 June 2020

Patient perception of the benefit of a BRAF inhibitor in metastatic melanoma: quality-of-life analyses of the BREAK-3 study comparing dabrafenib with dacarbazine

scientific article published on 25 April 2014

Patterns of care, prognosis, and survival in patients with metastatic gastrointestinal stromal tumors (GIST) refractory to first-line imatinib and second-line sunitinib

scientific article published on 8 November 2011

Patterns of recurrence and survival probability after second recurrence of retroperitoneal sarcoma: A study from TARPSWG

scientific article published on 14 August 2020

Peripheral Blood Cells from Patients with Hodgkin's and Diffuse Large B Cell Lymphomas May Be a Better Source of Candidate Diagnostic miRNAs Than Circulating miRNAs

scientific article published on 04 February 2021

Phase III study of nilotinib versus best supportive care with or without a TKI in patients with gastrointestinal stromal tumors resistant to or intolerant of imatinib and sunitinib.

scientific article

Pigmented/melanocytic malignant perivascular epithelioid cell tumor with TFE3-SFPQ(PSF) rearrangement - a challenging diagnosis of PEComa family of tumors

scientific article published on 01 January 2019

Plasma lncRNA expression profile as a prognostic tool in BRAF-mutant metastatic melanoma patients treated with BRAF inhibitor.

scientific article published on 11 June 2019

Polish clinical practice guideline on hyperthermic intraperitoneal chemotherapy (HIPEC) with cytoreductive surgery in peritoneal malignancy treatment

scientific article published on 29 August 2014

Post-relapse outcomes after primary extended resection of retroperitoneal sarcoma: A report from the Trans-Atlantic RPS Working Group.

scientific article published on 02 February 2017

Postoperative Morbidity After Radical Resection of Primary Retroperitoneal Sarcoma: A Report From the Transatlantic RPS Working Group.

scientific article published on 07 April 2017

Predicting Survival in Patients Undergoing Resection for Locally Recurrent Retroperitoneal Sarcoma: A Study and Novel Nomogram from TARPSWG

scientific article published on 05 February 2019

Predictive factors for long-term effects of imatinib therapy in patients with inoperable/metastatic CD117(+) gastrointestinal stromal tumors (GISTs)

scientific article published on 26 April 2007

Preoperative hypofractionated radiotherapy in the treatment of localized soft tissue sarcomas

scientific article published on 20 September 2014

Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial

scientific article published on 14 September 2020

Presence of homozygous KIT exon 11 mutations is strongly associated with malignant clinical behavior in gastrointestinal stromal tumors

scientific article published on 16 July 2007

Prevalence and Hypertension Treatment Schedule in Hemodialysis Patients and Renal Transplant Recipients in 2006 and 2014/2016

scientific article published on 15 March 2018

Principles of prophylactic and therapeutic management of skin toxicity during treatment with checkpoint inhibitors

scientific article published on 30 August 2019

Prognosis in patients with sentinel node-positive melanoma is accurately defined by the combined Rotterdam tumor load and Dewar topography criteria

scientific article

Prognosis in patients with sentinel node-positive melanoma without immediate completion lymph node dissection

scientific article

Prognostic and predictive value of AJCC-8 staging in the phase III EORTC1325/KEYNOTE-054 trial of pembrolizumab vs placebo in resected high-risk stage III melanoma

scientific article published on 11 June 2019

Prognostic impact of baseline tumour immune infiltrate on disease-free survival in patients with completely resected, BRAFv600 mutation-positive melanoma receiving adjuvant vemurafenib

scientific article published on 01 January 2020

Prognostic value of KIT/PDGFRA mutations in gastrointestinal stromal tumours (GIST): Polish Clinical GIST Registry experience

scientific article published on 28 April 2011

Prognostic value of multiple reverse transcription-PCR tyrosinase testing for circulating neoplastic cells in malignant melanoma.

scientific article

Prognostic value of the pretreatment neutrophil-to-lymphocyte ratio in patients with advanced gastrointestinal stromal tumors treated with sunitinib after imatinib failure

scientific article published on 16 July 2019

Prospective assessment of a gene signature potentially predictive of clinical benefit in metastatic melanoma patients following MAGE-A3 immunotherapeutic (PREDICT).

scientific article published on 08 August 2016

Quality of Surgery and Outcome in Localized Gastrointestinal Stromal Tumors Treated Within an International Intergroup Randomized Clinical Trial of Adjuvant Imatinib

scientific article published on 01 April 2020

Quality of surgery and surgical reporting for patients with primary gastrointestinal stromal tumours participating in the EORTC STBSG 62024 adjuvant imatinib study

scientific article published on 31 August 2019

Quality of treatment and surgical approach for rectal gastrointestinal stromal tumour (GIST) in a large European cohort

scientific article published on 06 March 2020

Quality-of-life evaluation in an interferon therapy after radical surgery in cutaneous melanoma patients

scientific article

Quiz. What is your diagnosis?

Radiotherapy for retroperitoneal liposarcoma: A report from the Transatlantic Retroperitoneal Sarcoma Working Group

scientific article published on 02 January 2019

Rational combination of cancer immunotherapy in melanoma

scientific article published on 14 December 2018

Rectal gastrointestinal stromal tumors associated with a novel germline KIT mutation

scientific article

Recurrent and novel SS18-SSX fusion transcripts in synovial sarcoma: description of three new cases

scientific article

Results of systemic treatment of cutaneous melanoma in inoperable stage III and IV

scientific article

Retrospective observational studies in ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society (CTOS) community of experts on the minimum requirements for the evaluation of activity of systemic treatments

scientific article published in 2022

Revealing the effect of electrocatalytic performance boost during hydrogen evolution reaction on free-standing SWCNT film electrode

scientific article

Risk Criteria and Prognostic Factors for Predicting Recurrences After Resection of Primary Gastrointestinal Stromal Tumor

scientific article published on 02 May 2007

Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts.

scientific article published on 06 December 2011

Risk stratification of sentinel node-positive melanoma patients defines surgical management and adjuvant therapy treatment considerations.

scientific article published on 13 April 2018

SOX10 is as specific as S100 protein in detecting metastases of melanoma in lymph nodes and is recommended for sentinel lymph node assessment

scientific article published on 08 August 2020

Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study

scientific article published on 16 July 2013

Safety and efficacy of nivolumab in challenging subgroups with advanced melanoma who progressed on or after ipilimumab treatment: A single-arm, open-label, phase II study (CheckMate 172)

scientific article published on 30 September 2019

Safety and efficacy of nivolumab in patients with rare melanoma subtypes who progressed on or after ipilimumab treatment: a single-arm, open-label, phase II study (CheckMate 172)

scientific article published on 21 August 2019

Sentinel lymph node biopsy in melanoma patients with clinically negative regional lymph nodes--one institution's experience

scientific article published in February 2003

Sentinel node tumor burden according to the Rotterdam criteria is the most important prognostic factor for survival in melanoma patients: a multicenter study in 388 patients with positive sentinel nodes

scientific article

Serum CD73 is a prognostic factor in patients with metastatic melanoma and is associated with response to anti-PD-1 therapy

scientific article published on 01 December 2020

Serum markers in early-stage and locally advanced melanoma

scientific article

Signatures of circulating microRNA in four sarcoma subtypes

scientific article published on 01 January 2020

Small bowel tumors detected and missed during capsule endoscopy: single center experience

scientific article published on December 2013

Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

scientific article published on 01 October 2018

Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

Sorafenib as third- or fourth-line treatment of advanced gastrointestinal stromal tumour and pretreatment including both imatinib and sunitinib, and nilotinib: A retrospective analysis.

scientific article

Spotlight on landmark oncology trials: the latest evidence and novel trial designs.

scientific article published on 2 June 2017

Standardy leczenia żywieniowego w onkologii

scientific article

Subcutaneous metastases from melanoma: a discussion of clinical experience

Succinate dehydrogenase-deficient GISTs: a clinicopathologic, immunohistochemical, and molecular genetic study of 66 gastric GISTs with predilection to young age

scientific article

Surgery and radiotherapy in the treatment of cutaneous melanoma

scientific article published on August 2009

Surgery combined with brachytherapy in patients with retroperitoneal sarcomas

scientific article published on March 2010

Surgery combined with intraoperative brachytherapy in the treatment of retroperitoneal sarcomas

scientific article

Surgery of primary melanomas.

scientific article

Surgery quality and tumor status impact on survival and local control of resectable liposarcomas of extremities or the trunk wall.

scientific article published on March 2013

Surgical downstaging in an open-label phase II trial of denosumab in patients with giant cell tumor of bone

scientific article

Surgical management of melanoma: an EORTC Melanoma Group survey

scientific article

Surgical management of metastatic gastrointestinal stromal tumour

scientific article published on 19 June 2018

Surgical resection of residual disease in initially inoperable imatinib-resistant/intolerant gastrointestinal stromal tumor treated with sunitinib

scientific article

Surgical treatment of patients with initially inoperable and/or metastatic gastrointestinal stromal tumors (GIST) during therapy with imatinib mesylate

scientific article published in March 2006

Survival Outcomes in Patients With Previously Untreated BRAF Wild-Type Advanced Melanoma Treated With Nivolumab Therapy: Three-Year Follow-up of a Randomized Phase 3 Trial

scientific article published on 01 February 2019

Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma

scientific article published on 3 October 2006

Systemic Treatment for Advanced and Metastatic Malignant Peripheral Nerve Sheath Tumors-A Sarcoma Reference Center Experience

scientific article published on 29 September 2020

Targeted Therapy in Melanoma and Mechanisms of Resistance ⬇️

scientific article published on 27 June 2020

Taxonomic position and phylogeny of the genus Vargasiella (Orchidaceae, Vandoideae) based on molecular and morphological evidence

scientific article published in 2014

Technical considerations in surgery for retroperitoneal sarcomas: position paper from E-Surge, a master class in sarcoma surgery, and EORTC-STBSG.

scientific article published on 03 April 2012

Ten-Year Progression-Free and Overall Survival in Patients With Unresectable or Metastatic GI Stromal Tumors: Long-Term Analysis of the European Organisation for Research and Treatment of Cancer, Italian Sarcoma Group, and Australasian Gastrointesti

scientific article published on 31 March 2017

The ENCCA-WP7/EuroSarc/EEC/PROVABES/EURAMOS 3rd European Bone Sarcoma Networking Meeting/Joint Workshop of EU Bone Sarcoma Translational Research Networks; Vienna, Austria, September 24-25, 2015. Workshop Report

scientific article published on 16 March 2016

The EORTC-DeCOG nomogram adequately predicts outcomes of patients with sentinel node-positive melanoma without the need for completion lymph node dissection

scientific article published on 23 May 2020

The Landmark Series: Systemic Therapy for Resectable Gastrointestinal Stromal Tumors

scientific article published on 30 July 2020

The Long-Term Outcomes of Intensive Combined Therapy of Adult Patients with Localised Synovial Sarcoma

scientific article published on 28 September 2020

The Megavoltage Radiation Therapy in Treatment of Patients With Advanced or Difficult Giant Cell Tumors of Bone

scientific article published on 11 December 2009

The Outcome of Targeted Therapy in Advanced Gastrointestinal Stromal Tumors (Gist) with Non-Exon 11 Kit Mutations

scientific article published on 01 July 2014

The Survival Benefit to Patients with Positive Sentinel Node Melanoma After Completion Lymph Node Dissection May Be Limited to the Subgroup with a Primary Lesion Breslow Thickness Greater Than 1.0 and Less Than or Equal to 4 mm (pT2–pT3)

scientific article published on 28 May 2008

The analysis of 3-year adjuvant therapy with imatinib in patients with high-risk molecular profiled gastrointestinal stromal tumors (GIST) treated in routine practice

scientific article published on 16 August 2020

The analysis of the long-term outcomes of sorafenib therapy in routine practice in imatinib and sunitinib resistant gastrointestinal stromal tumors (GIST).

scientific article published on 30 December 2017

The analysis of the outcomes and factors related to iliac-obturator involvement in cutaneous melanoma patients after lymph node dissection due to positive sentinel lymph node biopsy or clinically detected inguinal metastases.

scientific article published on 5 January 2013

The clinical characteristics and the role of surgery and imatinib treatment in patients with liver metastases from c-Kit positive gastrointestinal stromal tumors (GIST).

scientific article published in January 2003

The clinical prognostic factors and treatment outcomes of adult patients with Ewing sarcoma

scientific article published on 25 July 2020

The influence of the Miscanthus giganteus pyrolysis temperature on the application of obtained biochars as solid biofuels and precursors of high surface area activated carbons

The interval between primary melanoma excision and sentinel node biopsy is not associated with survival in sentinel node positive patients - An EORTC Melanoma Group study.

scientific article published on 27 May 2016

The long-term results and prognostic significance of cutaneous melanoma surgery using sentinel node biopsy with triple technique

scientific article

The long-term treatment outcomes of adult osteosarcoma

scientific article published on April 2017

The outcome and predictive factors of sunitinib therapy in advanced gastrointestinal stromal tumors (GIST) after imatinib failure - one institution study

scientific article

The outcomes of Polish patients with advanced BRAF-positive melanoma treated with vemurafenib in a safety clinical trial

scientific article

The prognostic role of BRAF and WNT pathways activation in kinase inhibitors-naïve clinical stage III cutaneous melanoma

scientific article published on 17 February 2020

The safety of regorafenib for the treatment of gastrointestinal stromal tumors.

scientific article published on 11 December 2015

The tyrosine kinase inhibitor crizotinib does not have clinically meaningful activity in heavily pre-treated patients with advanced alveolar rhabdomyosarcoma with FOXO rearrangement: European Organisation for Research and Treatment of Cancer phase 2

scientific article

Three-year pooled analysis of factors associated with clinical outcomes across dabrafenib and trametinib combination therapy phase 3 randomised trials

scientific article

Time to Definitive Failure to the First Tyrosine Kinase Inhibitor in Localized GI Stromal Tumors Treated With Imatinib As an Adjuvant: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Intergroup Randomi

scientific article published on 16 November 2015

Timing of completion lymphadenectomy after positive sentinel node biopsy in patients with melanoma.

scientific article published on 20 February 2017

Trametinib: a MEK inhibitor for management of metastatic melanoma

scientific article

Treatment Sequencing and Clinical Outcomes in BRAF-Positive and BRAF-Negative Unresectable and Metastatic Melanoma Patients Treated with New Systemic Therapies in Routine Practice

scientific article published on 01 December 2019

Treatment algorithms in stage IV melanoma

scientific article published on January 2015

Treatment of advanced dermatofibrosarcoma protuberans with imatinib mesylate with or without surgical resection.

scientific article

Treatment of gastrointestinal stromal tumours in paediatric and young adult patients with sunitinib: a multicentre case series

scientific article published on 6 November 2017

Treatment outcomes in older patients with advanced gastrointestinal stromal tumor (GIST).

scientific article published on 27 March 2018

Treatment results of adult patients with primary bone tumours of the humerus with the use of the oncological modular endoprosthesis

scientific article published on 29 September 2017

Tumor genotype is an independent prognostic factor in primary gastrointestinal stromal tumors of gastric origin: a european multicenter analysis based on ConticaGIST.

scientific article published on 7 October 2014

Use of extracellular vesicles from lymphatic drainage as surrogate markers of melanoma progression and BRAF V600E mutation

scientific article published on 11 April 2019

Validation of the Joensuu risk criteria for primary resectable gastrointestinal stromal tumour – The impact of tumour rupture on patient outcomes

scientific article published on 07 July 2011

Value of planar lymphoscintigraphy (PL) versus SPECT/CT in evaluation of sentinel lymph node in trunk melanoma - one center, large series retrospective study

scientific article published on 29 June 2018

Variability in Patterns of Recurrence After Resection of Primary Retroperitoneal Sarcoma (RPS): A Report on 1007 Patients From the Multi-institutional Collaborative RPS Working Group.

scientific article published on 31 December 2015

Venous thromboembolism prophylaxis in cancer patients — guidelines focus on surgical patients

What are the current outcomes of advanced gastrointestinal stromal tumors: who are the long-term survivors treated initially with imatinib?

scientific article

What is new in melanoma after European Cancer Congress 2017?

article

Which medical disciplines diagnose and treat melanoma in Europe in 2019? A survey of experts from melanoma centers in 27 European countries

scientific article published on 16 December 2020

Zasady stosowania dootrzewnowej chemioterapii w hipertermii (HIPEC) w leczeniu nowotworów złośliwych powierzchni otrzewnej w połączeniu z zabiegami cytoredukcyjnymi: zalecenia krajowe

scientific article published on 8 January 2015

[Cutaneous melanoma during pregnancy at the Cancer Center-Institute in Warsaw]

scientific article published on 01 July 2003

[Molecular-clinical issues of gastrointestinal stromal tumors].

scientific article

[The prognostic role of clinical factors, VEGF, IL-8 and sTNF-R1 in cutaneous melanomas at locoregional stage]

scientific article published on 01 January 2012

Paulina is supported by:

About Paulina

Help